Along with receiving a diagnosis of prostate cancer, comes new medical terminology that is likely unfamiliar to most men. One of the terms a man will hear is what is called a Gleason score. In 1966, a grading system for prostate cancer was developed by Dr. Donald Gleason. The Gleason score, still bearing his name today, is a system used to grade the aggressiveness of prostate cancer tissue.
Read MoreActive Surveillance/Watchful Waiting. These are not types of treatment, but ways to monitor prostate cancer when it is very low-risk or slow growing. During active surveillance or watchful waiting, your doctor will keep track of the prostate cancer using various tests including a PSA blood test, digital rectal exam, and ultrasound. If the prostate cancer becomes more aggressive, your doctor may recommend other treatment options.
Read MoreWhat is Cyberknife? Cyberknife is a form of stereotactic body radiation therapy (SBRT) and robotic-assisted radiosurgery (not actual surgery) that utilizes a computerized robot to automatically deliver high doses of radiation to the prostate gland. Fiducials are implanted into the body so that the Cyberknife machine can adjust to movement during each treatment.
Read MoreA new study from Australia suggests that robotic-assisted laparoscopic radical prostatectomy is more effective at preserving erectile function and urinary continence than a laparoscopic radical prostatectomy for treating localized prostate cancer. The study was recently published as a meta-analysis in Urologia Internationalis. The study was conducted by researchers at Monash University in Melbourne, Australia. It involved two randomized controlled trials and included a total of 232 patients in which each of their surgical approaches were compared.
Read MoreIf you’re one of the 230,000 men diagnosed with prostate cancer every year, you’re probably dealing with a dilemma of which treatment option to choose. Your doctor has likely spoken with you about radiation and surgery, but how do you choose?
Read MoreProstate cancer is one of the most common types of cancer in men. It starts in the prostate gland, which is a small walnut-shaped gland that is responsible for the production of seminal fluid. Prostate cancer is often a slow growing disease, but in some cases and depending on certain risk factors, it can be an aggressive disease and spread rather quickly.
Read MoreProstate cancer affects almost 234,000 men each year. Here are 11 treatment options to educate men diagnosed with prostate cancer.
Read MoreThe U.S. Preventive Services Task Force recommends against PSA (prostate specific antigen) screening for prostate cancer. The task force currently gives PSA screening a grade D, meaning that there is moderate or high certainty that the PSA test has no benefit or that the harms outweigh the benefits. This recommendation was first issued in 2011.
Read MoreWho's at risk for prostate cancer? Knowing your risk factors such as lifestyle habits and family history can save your life. Knowledge is power. Here's what men and women need to know.
Read MoreWhy is this important? Because prostate cancer is to men as breast cancer is to women. And just as with any other cancer, an early understanding of your risk factors and how to potentially reduce them is tremendously valuable. We explore.
Read More
Men diagnosed with both conditions have significantly reduced chances of survival. Emotions of pity, powerlessness, and other indications of depression are commonplace and reasonable in someone who has been diagnosed with prostate cancer.
Read MoreThe treatment options for prostate cancer can vary depending on a number of factors. These factors also affect the prognosis of the disease. The most important factor when determining which treatment option is best is the stage of the prostate cancer.
Read More
